SARS-CoV-2 Infection

Showing NaN - NaN of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2 (Omi XBB.1.5))

Not yet recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2 (Omi XBB.1.5)
  • Dublin, California
  • +14 more
Aug 10, 2023

SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2)

Completed
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • Anaheim, California
  • +20 more
Nov 30, 2022

SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (BNT162b2, Placebo, BNT162b2 OMI)

Recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +4 more
  • Athens, Alabama
  • +158 more
Jul 18, 2022

SARS-CoV-2 Infection Trial in United States (Evusheld (tixagevimab+cilgavimab) IM or IV)

Recruiting
  • SARS-CoV-2 Infection
  • Evusheld (tixagevimab+cilgavimab) IM or IV
  • Fountain Valley, California
  • +33 more
Jun 24, 2022

COVID on Children and Families

Recruiting
  • SARS-CoV-2 Infection
    • Birmingham, Alabama
    • +64 more
    May 5, 2022

    SARS-CoV-2 Infection Trial in Worldwide (Intramuscular injection, Intramuscular vaccine)

    Active, not recruiting
    • SARS-CoV-2 Infection
    • Intramuscular injection
    • Intramuscular vaccine
    • Birmingham, Alabama
    • +90 more
    Apr 4, 2022

    Pneumococcal Disease, COVID-19, SARS-CoV-2 Infection Trial in United States (20-valent pneumococcal conjugate vaccine (20vPnC),

    Completed
    • Pneumococcal Disease
    • +2 more
    • 20-valent pneumococcal conjugate vaccine (20vPnC)
    • +2 more
    • Anaheim, California
    • +28 more
    Mar 23, 2022